Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients

ConclusionsThe Switch strategy may expose the patients to an increased risk of developing SPC. The use of switch should be advocated with caution until robust pre-clinical and clinical data are available.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research